首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   348篇
  免费   9篇
儿科学   5篇
基础医学   48篇
口腔科学   1篇
临床医学   37篇
内科学   76篇
皮肤病学   6篇
神经病学   8篇
外科学   61篇
综合类   30篇
预防医学   44篇
眼科学   3篇
药学   22篇
中国医学   1篇
肿瘤学   15篇
  2023年   1篇
  2022年   5篇
  2021年   6篇
  2020年   2篇
  2019年   27篇
  2018年   30篇
  2017年   4篇
  2016年   10篇
  2015年   4篇
  2014年   16篇
  2013年   16篇
  2012年   7篇
  2011年   28篇
  2010年   16篇
  2009年   18篇
  2008年   11篇
  2007年   12篇
  2006年   17篇
  2005年   6篇
  2004年   8篇
  2003年   8篇
  2002年   6篇
  2001年   13篇
  2000年   10篇
  1999年   6篇
  1998年   10篇
  1997年   5篇
  1996年   6篇
  1995年   5篇
  1994年   7篇
  1993年   4篇
  1992年   4篇
  1991年   10篇
  1990年   3篇
  1989年   4篇
  1988年   3篇
  1985年   1篇
  1984年   3篇
  1983年   1篇
  1979年   1篇
  1976年   1篇
  1975年   1篇
  1974年   1篇
排序方式: 共有357条查询结果,搜索用时 15 毫秒
71.
剥切肋骨与切皮痛应激的对比研究   总被引:1,自引:1,他引:0  
为了比较剥切肋骨和切皮的痛应激强度,选择20例开胸手术病人,测定吸入53%N2O时七氟醚的剥切肋骨和切皮MAC,并监测循环应激反应。结果表明,七氟醚的剥切肋骨MAC(MACRE)与切皮MAC(MACSI)数值相同,均为0.84±0.02%。但循环监测显示,剥切肋骨时血压和心率升高比切皮时更显著(P<0.001)。提示在同一麻醉深度剥切肋骨的痛应激反应比切皮时稍大。  相似文献   
72.
曲马多对异氟醚的MAC和循环的影响   总被引:3,自引:0,他引:3  
观察41例患者应用曲马多后对异氟醚MAC的影响及对血液动力学的影响。静滴曲马多2mg/kg,在31~55岁组和≥56岁组患者的异氟酸MAC值分别为1.07%和0.96%,静滴曲马多4mg/kg,在这两个年龄组异氟醚MAC值分别为0.98%和0.90%。和基础值相比,静滴由马多4mg/kg后患者心率和血压分别增加 23. 5%(P<0. 001)和 7. 7%(P<0. 001), 10分钟后 Ⅱ组患者的心率和血压均显著高于Ⅰ组(P<0.02和0.002)。结果表明,曲马多可强化吸入麻醉药,大剂量时还有明显的循环效应。  相似文献   
73.
目的 探讨N^G-硝基-L-精氨酸甲酯(L-NAME)的抗伤害作用及其对异氟醚麻醉作用、大鼠大脑不同脑区突触体一氧化氮合酶(NOS)活性和一氧化氮(NO)的影响。方法 30只雄性SD大鼠,随机分为生理盐水对照组、L-NAME异氟醚组和L-NAME抗伤害组;分别测定给予L-NAME后大鼠的甩尾潜伏期(TFL)、最大镇痛效应百分率(%MPE)、异氟醚最低肺泡有效浓度(MAC)和大鼠不同脑区粗制突触体NOS活性以及NO的生成。结果 L-NAME可延长大鼠的TEL,增加%MPE,降低异氟醚的MAC,抑制大脑不同脑区突触体NOS活性和NO的生成(P〈0.01)。结论 L-NAME能通过对中枢神经系统突触体NOS活性和NO生成的抑制,发挥其抗伤害和减轻异氟醚麻醉作用。  相似文献   
74.
75.
76.

Objectives

The aim of this study was to gain insight into the causes and outcomes of patients who do not qualify for transcatheter mitral valve replacement (TMVR).

Background

Despite the increasing availability of TMVR, patients with severe mitral regurgitation may not be eligible. Thus far, no investigation has examined ineligible patients and their clinical outcomes.

Methods

A total of 203 patients (mean age 79 ± 9 years, 48% men) who were ineligible for participation in early feasibility studies of TMVR were examined.

Results

The ineligibility rate for TMVR was 89.0%. The most common reasons for TMVR exclusion were excessive frailty (15.3%), severe tricuspid regurgitation (15.3%), and prior aortic valve therapy (14.2%). Mitral anatomic exclusions were present in 15.8%, with severe annular calcification in 7.4%, and risk for left ventricular outflow tract obstruction was notably infrequent (4.4%). Overall, 76 patients (37.4%) did not undergo subsequent commercial surgical or transcatheter mitral therapy. Patients not eligible for TMVR and not treated commercially had high rates of cardiac death (11.8%) and death or heart failure hospitalization (22.4%) at 1 year. These rates were significantly higher than those who underwent surgery (2.4% for cardiac death; p < 0.001; 5.5% for heart failure hospitalization; p = 0.003) and remained worse after excluding patients with excessive frailty or medical futility and in multivariate modeling that adjusted for baseline differences.

Conclusions

Patients ineligible for TMVR and treated medically have poor outcomes. These data and the high rate of TMVR screen failure support the need for therapy iteration as well as development of alternative means of management, with the goal of improving the prognosis of these patients.  相似文献   
77.
陈毅翀  赵毅 《现代肿瘤医学》2019,(18):3167-3171
目的:探讨MAC30在乳腺癌中的作用和机制。方法:使用慢病毒介导的Lenti-shRNA来沉默乳腺癌细胞MCF7和MDA-MB-231中MAC30的表达,并通过Western Blot检测相关蛋白的表达;采用CCK8法检测细胞增殖;Annexin V-FITC/PI双染色法检测细胞凋亡。结果:MAC30的表达下调后乳腺癌细胞的增殖率减少且凋亡率增加,通过Western Blot,发现MAC30 敲低后p-AKT,Cyclin D1和Bcl-2的表达明显下降,而BAX的表达增高。结论:敲减MAC30的表达后,可以明显抑制乳腺癌细胞增殖并诱导其凋亡,而MAC30可能是通过PI3K/AKT信号通路来调控乳腺癌的发生发展过程。因此,MAC30可能是一个治疗乳腺癌的潜在治疗靶点。  相似文献   
78.
韩氏(HANS)仪对七氟醚最低肺泡浓度(MAC)的影响   总被引:9,自引:2,他引:9  
目的:将HANS仪用于心血管手术的临床麻醉,观察其能否减少麻醉药的用量。方法:40例5~10岁先天性心脏病室间隔缺损(VSD)、房间隔缺损(ASD)患儿,随机分为Ⅰ组(单用七氟醚组)和Ⅱ组(HANS加七氟醚复合组)。用体动反应上下交叉点(upanddown)法分别测定两组的最低肺泡气浓度(MAC)。结果:Ⅰ组即单用七氟醚组的MAC值为2.72±0.07Vol%;而Ⅱ组即七氟醚加HANS组的MAC值为2.24±0.15Vol%,比空白组减少了17.4%。两组间P值<0.001,有非常显著的区别。切皮的刺激使Ⅰ组的心率增加了38.0%,收缩压增加了23.0%,舒张压增加了34.0%;而Ⅱ组即七氟醚加HANS组心率增加了16.0%,收缩压增加了14.3%,舒张压增加了13.7%。结论:HANS可减少七氟醚的MAC值17.38%,具有非常显著的统计学意义。在1MAC左右,机体接受同样伤害性刺激时,HANS具有一定的心血管稳定作用。  相似文献   
79.
Bone marrow (BM) aspiration and biopsy are used commonly in clinical practice to diagnose invasive tissue infections caused by Mycobacterium avium intracellulare (MAC), Mycobacterium tuberculosis (TB), and Histoplasma capsulatum (HC) in patients with human immunodeficiency virus-1 (HIV) infection. However, the value of these invasive procedures relative to other diagnostic approaches has not been clearly defined. To determine the value of BM culture and BM histology in the diagnosis of opportunistic MAC/TB and HC infections in immunosuppressed patients with HIV, we retrospectively reviewed the records of 56 adult patients with HIV who underwent a single BM aspiration, biopsy, and culture because of unexplained fever and/or other clinical features suggestive of MAC/TB or HC infection. Thirty-two patients (57%) were ultimately diagnosed with MAC/TB or HC infection by positive cultures of BM, blood, sputum, or bronchoalveolar lavage fluid or by the histologic detection of organisms in biopsies of BM or other tissues. The diagnostic sensitivity of BM cultures was equal to that of blood cultures (20/32, or 63%). Granuloma and/or histologically apparent organisms were seen in BM biopsy specimens in 11 of 32 individuals (34%) ultimately diagnosed with MAC/TB or HC infections. Among these 11 cases, both granuloma and acid-fast staining organisms were found in the BM biopsy specimens of 2 individuals for whom both BM and blood cultures were negative. Certain clinical symptoms and signs at the time of BM examination were found by logistic regression analysis to be significantly associated with a subsequent diagnosis of MAC/TB or HC infections; these included high fever, long duration of febrile days prior to BM examination, and elevated direct bilirubin. In conclusion, while the diagnostic sensitivity of BM cultures was found to be no greater than that of blood cultures in detecting MAC/TB or HC infections in immunosuppressed HIV+ patients, histopathologic examination of BM specimens resulted in the relatively rapid identification of nearly one third of infected patients who underwent BM examination, and also identified infections in some patients who were culture negative. These findings support the continued use of BM aspiration, biopsy, and culture for the diagnosis of opportunistic MAC/TB or HC infections in immunosuppressed HIV+ patients, particularly when selected clinical features are present.  相似文献   
80.

Background

The risk of surgical mitral valve replacement in patients with severe mitral annular calcification (MAC) is high. Several patients worldwide with severe MAC have been treated successfully with transcatheter mitral valve replacement (TMVR) using balloon-expandable aortic transcatheter valves. The TMVR in MAC Global Registry is a multicenter registry that collects data on outcomes of these procedures.

Objectives

The goal of this study was to evaluate 1-year outcomes in this registry.

Methods

This study was a multicenter retrospective review of clinical outcomes.

Results

A total of 116 extreme surgical risk patients with severe MAC underwent TMVR; 106 had a procedure date >1 year before data-lock and were included in the analysis. Their mean age was 73 ± 12 years, and 68% were female. The mean Society of Thoracic Surgeons score was 15.3 ± 11.6%, and 90% were in New York Heart Association functional class III or IV. Thirty-day and 1-year all-cause mortality was 25% and 53.7%, respectively. Most patients who survived 30 days were alive at 1 year (49 of 77 [63.6%]), and the majority (71.8%) were in New York Heart Association functional class I or II. Echocardiography data at 1 year were available in 34 patients. Mean left ventricular ejection fraction was 58.6 ± 11.2%, mean mitral valve area was 1.9 ± 0.5 cm2, mean mitral gradient was 5.8 ± 2.2 mm Hg, and 75% had zero or trace mitral regurgitation.

Conclusions

TMVR with balloon-expandable aortic valves in extreme surgical risk patients with severe MAC is feasible but associated with high 30-day and 1-year mortality. Most patients who survive the 30-day post-procedural period are alive at 1 year and have sustained improvement of symptoms and transcatheter valve performance. The role of TMVR in patients with MAC requires further evaluation in clinical trials.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号